FDA Inspection
Element Materials Technology Boston - Acton Inc.Element Materials Technology Boston - Acton Inc. – FDA Inspection, Jan 15, 2019
Record Details
This FDA Inspection record concerns Element Materials Technology Boston - Acton Inc., with an inspection on January 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- January 15, 2019
- Product Type
- Drugs
View Company Profile
ID · 80e1f7be-3cdf-476d-bd83-537db7ca64ba
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1076495
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.160(a)Following/documenting laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Element Materials Technology Boston - Acton Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 4, 2026 | VAI | New England District Office | Drug Quality Assurance |
| August 1, 2025 | Not classified | New England District Office | Human Cellular, Tissue, and Gene Therapies |
| May 9, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 10, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 27, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Element Materials Technology Boston - Acton Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.